BOHEMIA, N.Y., Aug. 8, 2003 (PRIMEZONE) -- Scientific Industries Inc. (OTCBB:SCND), manufacturer of the original Vortex-Genie(r), has engaged several independent sales representatives, covering various regions throughout the United States, for the promotion and distribution of two new products, the BioReactor Genie(tm) and the Bag Rotator.
The BioReactor Genie(tm) is a compact benchtop culture chamber designed to provide optimal growth conditions for a variety of cell types including bacteria, plant, and animal cells.
The Bag Rotator gently and effectively mixes transfer packs or other sealed bags, maintaining platelets and other sample components in suspension without risk of damage. The Company believes that the economical Bag Rotator is ideal for use with blood product samples, or almost any sealed bag that requires extremely gentle mixing, or suspension of its contents.
"The engagement of independent sales representatives," noted Helena Santos, President and CEO of Scientific Industries, "is one component of the Company's new strategy to expand our existing distribution network, penetrate unique and untapped markets, and increase revenue."
About Scientific Industries
Scientific Industries manufactures and markets laboratory equipment, including the world-renowned Vortex-Genie(r) 2 Mixer. Scientific Industries' products are used by research laboratories, clinics, pharmaceutical manufacturers, medical device manufacturers, and other industries.
"Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-KSB."